CAS: 1037792-44-1 - MBX-2982
- Sinónimos:
- Pyrimidine, 5-Ethyl-2-[4-[4-[[4-(1H-Tetrazol-1-Yl)Phenoxy]Methyl]-2-Thiazolyl]-1-Piperidinyl]-
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
MBX2982 REF: IN-DA008THQCAS: 1037792-44-1 | 98% | A consultar | Mar 21 Ene 25 | |
MBX-2982 REF: TM-T1793CAS: 1037792-44-1 | 98% - 99.96% | 50,00 €~738,00 € | Lun 27 Ene 25 | |
5-Ethyl-2-[4-[4-[[[4-(1H-tetrazol-1-yl)phenyl]oxy]methyl]thiazol-2-yl]piperidin-1-yl]pyrimidine REF: 3D-FE58289CAS: 1037792-44-1 | Min. 95% | 136,00 €~904,00 € | Mié 29 Ene 25 |
Ref: IN-DA008THQ
5mg | 118,00 € | ||
10mg | 179,00 € | ||
25mg | 218,00 € | ||
50mg | 488,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
MBX-2982
CAS:1037792-44-1
MBX-2982 is a selective, orally-available GPR119 agonist, used for the treatment of diabetes.
Fórmula:
C22H24N8OS
Pureza:
98% - 99.96%
Forma y color:
Solid
Peso molecular:
448.54
Ref: TM-T1793
1mg | 50,00 € | ||
2mg | 71,00 € | ||
5mg | 106,00 € | ||
10mg | 176,00 € | ||
25mg | 343,00 € | ||
50mg | 525,00 € | ||
100mg | 738,00 € | ||
1mL*10mM (DMSO) | 116,00 € |
Entrega estimada en Estados Unidos, el Lunes 27 de Enero de 2025
5-Ethyl-2-[4-[4-[[[4-(1H-tetrazol-1-yl)phenyl]oxy]methyl]thiazol-2-yl]piperidin-1-yl]pyrimidine
CAS:1037792-44-1
Please enquire for more information about 5-Ethyl-2-[4-[4-[[[4-(1H-tetrazol-1-yl)phenyl]oxy]methyl]thiazol-2-yl]piperidin-1-yl]pyrimidine including the price, delivery time and more detailed …
Fórmula:
C22H24N8OS
Pureza:
Min. 95%
Forma y color:
Powder
Peso molecular:
448.55 g/mol
Ref: 3D-FE58289
5mg | 284,00 € | ||
10mg | 426,00 € | ||
25mg | 569,00 € | ||
50mg | 722,00 € | ||
100mg | 904,00 € |
Entrega estimada en Estados Unidos, el Miércoles 29 de Enero de 2025